Publications by authors named "Roseline Ruetsch"

Article Synopsis
  • The variety of biological therapies for inflammatory bowel disease (IBD) has significantly increased, with the number available doubling in the last decade and new treatments like interleukin 23p19 inhibitors being introduced.* -
  • Properly positioning these advanced therapies based on factors such as clinical situation, effectiveness, and safety is essential for delivering personalized IBD treatment.* -
  • This publication summarizes recent literature and expert insights to help integrate comparative efficacy data and patient demographics into clinical practice for better decision-making regarding biological therapies.*
View Article and Find Full Text PDF